Advertisement
Screener

Tango Therapeutics, Inc. (TNGX) Net Margin

Tango Therapeutics, Inc. (TNGX) Net Margin

  • 2025-09-30: Net Margin 29.52%.
  • 2025-06-30: Net Margin -1221.41%.
  • 2025-03-31: Net Margin -739.54%.
  • 2024-12-31: Net Margin -914.99%.

Complete source-backed net margin history.

Available history
2020-09-30 to 2025-12-31
Data captured

Historical Net Margin

DateNet Margin
2025-09-3029.52%
2025-06-30-1221.41%
2025-03-31-739.54%
2024-12-31-914.99%
2024-09-30-251.29%
2024-06-30-128.56%
2024-03-31-585.91%
2023-12-31-566.43%
2023-09-30-207.45%
2023-06-30-141.87%
2023-03-31-485.74%
2022-12-31-453.28%
2022-09-30-419.80%
2022-06-30-430.74%
2022-03-31-437.79%
2021-12-31-385.69%
2021-09-30-288.64%
2021-06-30-24.75%
2021-03-31-189.57%
2020-12-31-96.96%
2020-09-30238.01%

Annual Net Margin

DateNet Margin
2025-12-31-162.85%
2024-12-31-309.73%
2023-12-31-278.54%
2022-12-31-435.14%
2021-12-31-157.21%
2020-12-31-678.84%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Indivior Pharmaceuticals, Inc. (INDV)$4.250B14.09
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51
AbCellera Biologics Inc. (ABCL)$3.879B-14.59
Edgewise Therapeutics, Inc. (EWTX)United States$4.470B-22.23
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
Organon & Co. (OGN)United States$3.603B17.03
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Veradermics, Inc (MANE)United States$4.839B
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15